Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-13 4:57 pm Purchase | 2024-09-11 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 7,941,673 19.990% | 1,330,418 (+20.12%) | Filing History |
| 2024-09-06 5:08 pm Purchase | 2024-08-29 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 6,611,255 19.990% | 6,611,255 (New Position) | Filing History |
| 2024-07-05 5:20 pm Purchase | 2024-07-02 | 13G | ARCA biopharma, Inc. ABIO | JANUS HENDERSON GROUP PLC JHG | 123,545 10.200% | 33,536 (+37.26%) | Filing History |
| 2024-04-29 7:28 pm Purchase | 2024-04-17 | 13G | ARCA biopharma, Inc. ABIO | Venrock Healthcare Capital Partners III, L.P. | 62,889 5.200% | 62,889 (New Position) | Filing History |
| 2024-04-15 5:29 pm Purchase | 2024-04-03 | 13G | ARCA biopharma, Inc. ABIO | Allostery Investments LP | 88,751 7.300% | 88,751 (New Position) | Filing History |
| 2024-04-11 09:51 am Purchase | 2024-04-03 | 13G | ARCA biopharma, Inc. ABIO | JANUS HENDERSON GROUP PLC JHG | 90,009 7.400% | 90,009 (New Position) | Filing History |
| 2024-04-09 8:57 pm Purchase | 2024-04-03 | 13G | ARCA biopharma, Inc. ABIO | Avidity Partners Management LP | 83,333 6.900% | 83,333 (New Position) | Filing History |
| 2024-04-05 7:38 pm Purchase | 2023-12-31 | 13G | ARCA biopharma, Inc. ABIO | Western Standard LLC | 117,512 9.800% | 38,826 (+49.34%) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-03 | 13D | ARCA biopharma, Inc. ABIO | Adage Capital Management, L.P. | 100,000 8.280% | 100,000 (New Position) | Filing History |
| 2024-02-07 1:08 pm Sale | 2023-12-31 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 58,911 4.900% | -12,611 (-17.63%) | Filing History |
| 2023-09-11 4:01 pm Purchase | 2023-08-30 | 13G | ARCA biopharma, Inc. ABIO | Western Standard LLC | 78,686 6.600% | 78,686 (New Position) | Filing History |
| 2023-02-08 2:48 pm Purchase | 2023-02-08 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 71,521 5.950% | 8,033 (+12.65%) | Filing History |
| 2022-07-08 4:30 pm Purchase | 2022-07-01 | 13D | ARCA biopharma, Inc. ABIO | Funicular Funds, LP | 215,093 17.910% | 215,093 (New Position) | Filing History |
| 2022-06-21 4:30 pm Purchase | 2022-06-15 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 215,093 17.910% | 15,320 (+7.67%) | Filing History |
| 2022-05-27 4:40 pm Purchase | 2022-05-25 | 13D | ARCA biopharma, Inc. ABIO | Ma-Weaver Jacob | 215,038 17.910% | 215,038 (New Position) | Filing History |
| 2022-05-11 4:56 pm Purchase | 2022-05-09 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 199,773 16.640% | 18,848 (+10.42%) | Filing History |
| 2022-04-14 4:38 pm Purchase | 2022-04-12 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 180,925 15.060% | 18,842 (+11.63%) | Filing History |
| 2022-04-04 5:10 pm Purchase | 2022-03-31 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 162,083 13.500% | 84,163 (+108.01%) | Filing History |
| 2022-03-28 4:20 pm Purchase | 2022-03-18 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 77,920 6.490% | 77,920 (New Position) | Filing History |
| 2022-01-27 3:53 pm Purchase | 2022-01-24 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 63,488 5.300% | 63,488 (New Position) | Filing History |